326 related articles for article (PubMed ID: 37414364)
1. Theophylline reverses oxycodone's but not fentanyl's respiratory depression in mice while caffeine is ineffective against both opioids.
Elder HJ; Walentiny DM; Beardsley PM
Pharmacol Biochem Behav; 2023 Aug; 229():173601. PubMed ID: 37414364
[TBL] [Abstract][Full Text] [Related]
2. Amphetamines modulate fentanyl-depressed respiration in a bidirectional manner.
Elder HJ; Varshneya NB; Walentiny DM; Beardsley PM
Drug Alcohol Depend; 2023 Feb; 243():109740. PubMed ID: 36608481
[TBL] [Abstract][Full Text] [Related]
3. Fentanyl depression of respiration: Comparison with heroin and morphine.
Hill R; Santhakumar R; Dewey W; Kelly E; Henderson G
Br J Pharmacol; 2020 Jan; 177(2):254-266. PubMed ID: 31499594
[TBL] [Abstract][Full Text] [Related]
4. Opioid-induced respiratory effects: new data on buprenorphine.
Dahan A
Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215
[TBL] [Abstract][Full Text] [Related]
5. Methocinnamox Reverses and Prevents Fentanyl-Induced Ventilatory Depression in Rats.
Jimenez VM; Castaneda G; France CP
J Pharmacol Exp Ther; 2021 Apr; 377(1):29-38. PubMed ID: 33431611
[TBL] [Abstract][Full Text] [Related]
6. Non-analgesic effects of opioids: opioid-induced respiratory depression.
Boom M; Niesters M; Sarton E; Aarts L; Smith TW; Dahan A
Curr Pharm Des; 2012; 18(37):5994-6004. PubMed ID: 22747535
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and preliminary evaluation of a potential synthetic opioid rescue agent.
Hedrick SL; Luo D; Kaska S; Niloy KK; Jackson K; Sarma R; Horn J; Baynard C; Leggas M; Butelman ER; Kreek MJ; Prisinzano TE
J Biomed Sci; 2021 Sep; 28(1):62. PubMed ID: 34503531
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological Profiling of Antifentanyl Monoclonal Antibodies in Combination with Naloxone in Pre- and Postexposure Models of Fentanyl Toxicity.
Baehr CA; Wu MM; Pandit SG; Arias-Umana J; AuCoin D; Pravetoni M
J Pharmacol Exp Ther; 2022 May; 381(2):129-136. PubMed ID: 35153198
[TBL] [Abstract][Full Text] [Related]
9. Development of a Translational Model to Assess the Impact of Opioid Overdose and Naloxone Dosing on Respiratory Depression and Cardiac Arrest.
Mann J; Samieegohar M; Chaturbedi A; Zirkle J; Han X; Ahmadi SF; Eshleman A; Janowsky A; Wolfrum K; Swanson T; Bloom S; Dahan A; Olofsen E; Florian J; Strauss DG; Li Z
Clin Pharmacol Ther; 2022 Nov; 112(5):1020-1032. PubMed ID: 35766413
[TBL] [Abstract][Full Text] [Related]
10. Noradrenergic Mechanisms in Fentanyl-Mediated Rapid Death Explain Failure of Naloxone in the Opioid Crisis.
Torralva R; Janowsky A
J Pharmacol Exp Ther; 2019 Nov; 371(2):453-475. PubMed ID: 31492824
[TBL] [Abstract][Full Text] [Related]
11. Reversal and Prevention of the Respiratory-Depressant Effects of Heroin by the Novel
Gerak LR; Maguire DR; Woods JH; Husbands SM; Disney A; France CP
J Pharmacol Exp Ther; 2019 Feb; 368(2):229-236. PubMed ID: 30463875
[TBL] [Abstract][Full Text] [Related]
12. In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profile.
Kuo A; Wyse BD; Meutermans W; Smith MT
Br J Pharmacol; 2015 Jan; 172(2):532-48. PubMed ID: 24641546
[TBL] [Abstract][Full Text] [Related]
13. Reversal of morphine, methadone and heroin induced effects in mice by naloxone methiodide.
Lewanowitsch T; Miller JH; Irvine RJ
Life Sci; 2006 Jan; 78(7):682-8. PubMed ID: 16102783
[TBL] [Abstract][Full Text] [Related]
14. Methylxanthine reversal of opioid-evoked inspiratory depression via phosphodiesterase-4 blockade.
Ruangkittisakul A; Ballanyi K
Respir Physiol Neurobiol; 2010 Jul; 172(3):94-105. PubMed ID: 20444435
[TBL] [Abstract][Full Text] [Related]
15. Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids.
Dahan A; Franko TS; Carroll JW; Craig DS; Crow C; Galinkin JL; Garrity JC; Peterson J; Rausch DB
Front Public Health; 2024; 12():1346109. PubMed ID: 38481848
[TBL] [Abstract][Full Text] [Related]
16. Fentanyl causes naloxone-resistant vocal cord closure: A platform for testing opioid overdose treatments.
Miner NB; Schutzer WE; Zarnegarnia Y; Janowsky A; Torralva R
Drug Alcohol Depend; 2021 Oct; 227():108974. PubMed ID: 34492557
[TBL] [Abstract][Full Text] [Related]
17.
Hiranita T; Ho NP; France CP
J Pharmacol Exp Ther; 2024 Feb; ():. PubMed ID: 38409115
[TBL] [Abstract][Full Text] [Related]
18. Heroin- and Fentanyl-Induced Respiratory Depression in a Rat Plethysmography Model: Potency, Tolerance, and Sex Differences.
Marchette RCN; Carlson ER; Frye EV; Hastings LE; Vendruscolo JCM; Mejias-Torres G; Lewis SJ; Hampson A; Volkow ND; Vendruscolo LF; Koob GF
J Pharmacol Exp Ther; 2023 May; 385(2):117-134. PubMed ID: 36828628
[TBL] [Abstract][Full Text] [Related]
19. Abuse of fentanyl: An emerging problem to face.
Kuczyńska K; Grzonkowski P; Kacprzak Ł; Zawilska JB
Forensic Sci Int; 2018 Aug; 289():207-214. PubMed ID: 29902699
[TBL] [Abstract][Full Text] [Related]
20. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
